Cantargia
1 follower
‌
Cantargia utvecklar en antikroppsbaserad behandling riktad mot målmolekylen IL1RAP som har potential att användas för ett flertal olika cancersjukdomar.
Industries
Headquarters
Employees
Links
Org chart
Göran Forsberg
Collapse
Dominique Tersago
Chief Medical Officer
David Liberg
VP, Research
Lars Thorsson
VP Clinical Development
Nedjad Losic
VP Biometrics
Marie Wallén Öhman
Senior Clinical Director
Ida Markholm
Senior Data Manager/Bioinformatician
Susanne Magnusson
Director Clinical Development
Similar companies
Forge Biologics
2 followers
Expansion Therapeutics
2 followers
Kyverna Therapeutics
5 followers
Neuron23
1 follower
Slingshot Biosciences
1 follower
Cellares
2 followers
Sano Genetics
2 followers
Astria Therapeutics
1 follower
Thermo Fisher Scientific
149 followers
Gilead Sciences
121 followers
Regeneron
89 followers
Discover companies